Post-approval studies (Phase 4)UnknownNCT00777504
What this trial is testing
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
Who this might be right for
Renal Cell CarcinomaGastrointestinal Stromal Tumor
Radboud University Medical Center 30